What are the best patient assessment tools for a patient with chronic long-standing insomnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Patient Assessment Tools for Chronic Long-Standing Insomnia

For chronic insomnia assessment, at minimum use: (1) a two-week sleep diary, (2) the Insomnia Severity Index (ISI), and (3) the Epworth Sleepiness Scale (ESS), supplemented by a general medical/psychiatric questionnaire to identify comorbid conditions. 1

Core Assessment Instruments (Required)

Sleep Diary - The Foundation

  • Complete a two-week sleep log prior to any treatment intervention to establish baseline sleep-wake patterns and day-to-day variability 1, 2
  • Document the following parameters daily:
    • Bedtime and rise time
    • Sleep onset latency (time to fall asleep)
    • Number and duration of nighttime awakenings
    • Wake after sleep onset (WASO)
    • Total sleep time and time in bed
    • Sleep efficiency percentage (total sleep time/time in bed × 100%)
    • Nap frequency, timing, and duration
    • Sleep quality ratings
    • Daytime impairment
    • Medications, caffeine, and alcohol consumption 1
  • Continue sleep diary collection during active treatment and at 6-month intervals for long-term monitoring, as relapse rates for insomnia are high 1

Insomnia Severity Index (ISI)

  • The ISI is the most widely used and validated tool to measure self-reported insomnia symptom severity 1, 3
  • This 7-item categorical scale provides total scores with established criteria for defining treatment response and remission 1
  • The ISI demonstrates strong internal consistency, concurrent validity with sleep diaries and polysomnography, and sensitivity to detect treatment changes 3
  • Use the ISI both at baseline and longitudinally to measure treatment response 1

Epworth Sleepiness Scale (ESS)

  • Administer the ESS to identify excessive daytime sleepiness and screen for comorbid sleep disorders such as sleep apnea 1, 2
  • Significant sleepiness should prompt investigation for other sleep disorders beyond insomnia 1

General Medical/Psychiatric Questionnaire

  • Complete a comprehensive questionnaire to identify comorbid medical and psychiatric disorders that may cause or perpetuate insomnia 1, 2
  • Screen specifically for:
    • Cardiovascular, pulmonary, neurological, pain, gastrointestinal, and endocrine conditions 1, 2
    • Depression, anxiety disorders, bipolar disorder, and post-traumatic stress disorder 2
    • Medications that disrupt sleep (SSRIs, stimulants, decongestants, beta-blockers, diuretics, theophylline) 1, 2
    • Substance use including caffeine, alcohol, nicotine, and recreational drugs 1, 2

Additional Validated Assessment Tools (Recommended)

Pittsburgh Sleep Quality Index (PSQI)

  • The PSQI measures global sleep quality and is one of the two most widely used tools alongside the ISI 1
  • This categorical scale provides total scores that can be evaluated across treatment with accepted criteria for treatment response 1
  • The PSQI has demonstrated adequate structural validity in chronic insomnia populations 4

Dysfunctional Beliefs and Attitudes About Sleep (DBAS) Scale

  • Include the DBAS to identify unhelpful sleep-related beliefs that perpetuate insomnia and to measure changes during cognitive-behavioral therapy 1

Daytime Function and Quality of Life Measures

  • Assess daytime impairments including fatigue, mood disturbances, cognitive difficulties, and overall quality of life, as these are what typically drive patients to seek treatment 1
  • Various validated self-report questionnaires for daytime fatigue should be included 1

Objective Assessment Tools (Selective Use Only)

When Polysomnography IS Indicated

  • Polysomnography is NOT indicated for routine evaluation of chronic insomnia 1
  • Order polysomnography only when:
    • Reasonable clinical suspicion exists for sleep-disordered breathing (sleep apnea) or movement disorders 1
    • Initial diagnosis remains uncertain after comprehensive evaluation 1
    • Treatment fails (both behavioral and pharmacologic interventions) 1
    • Precipitous arousals occur with violent or injurious behavior 1

Actigraphy

  • Consider wrist actigraphy for at least 7 days to objectively characterize circadian rhythm patterns or when circadian rhythm disorders are suspected 1, 2
  • Actigraphy provides complementary information to sleep diaries but is not required for diagnosis 1

Critical Assessment Considerations

Differential Diagnosis Requirements

  • Multiple insomnia disorders may coexist—the presence of one does not exclude others 1
  • Systematically evaluate for:
    • Sleep-related breathing disorders (obstructive sleep apnea)
    • Movement disorders (restless legs syndrome, periodic limb movements)
    • Circadian rhythm sleep disorders
    • Comorbid medical or psychiatric conditions
    • Primary insomnia subtypes (psychophysiological, idiopathic, paradoxical) 1

Bed Partner Interview

  • Include bed partner interviews when available to obtain collateral information about snoring, breathing pauses, movements, and sleep behaviors 1

What NOT to Order Routinely

  • Laboratory testing (blood work, radiographic studies) is NOT indicated for routine chronic insomnia evaluation unless specific suspicion exists for comorbid disorders 1
  • Daytime multiple sleep latency testing (MSLT) is NOT indicated in routine chronic insomnia evaluation 1

Common Pitfalls to Avoid

  • Failing to collect a two-week sleep diary before initiating treatment—this is essential for establishing baseline patterns and guiding behavioral interventions 1, 2
  • Ordering polysomnography for uncomplicated chronic insomnia—this wastes resources and is not guideline-recommended 1
  • Neglecting to screen for comorbid sleep disorders with the ESS, potentially missing treatable conditions like sleep apnea 1, 2
  • Using only subjective questionnaires without daily sleep diaries—diaries are less subject to recall bias and capture day-to-day variability 1
  • Failing to reassess with these same tools during treatment—repeated administration guides treatment adjustments and identifies relapse 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Comprehensive Workup for Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.